Hjem › Lungekreft › California › Santa Rosa
Kliniske studier for Lungekreft i Santa Rosa, CA
11 studier for Lungekreft søker deltakere på steder i og rundt Santa Rosa (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Kaiser Permanente-Santa Rosa, Santa Rosa
- Saint Helena Hospital, St. Helena · 14 mi unna
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekruttererFase 3
- Kaiser Permanente-Santa Rosa, Santa Rosa
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
- Kaiser Permanente-Santa Rosa, Santa Rosa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Providence Medical Foundation - Santa Rosa, Santa Rosa
- Providence Santa Rosa Memorial Hospital, Santa Rosa
- Saint Helena Hospital, St. Helena · 14 mi unna
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruttererFase 3
- Kaiser Permanente-Santa Rosa, Santa Rosa
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekruttererFase 3
- Sutter Pacific Medical Foundation, Santa Rosa
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruttererFase 1/2
- Providence Medical Foundation, Santa Rosa
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Sutter Pacific Medical Foundation, Santa Rosa
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- St Joseph Heritage Healthcare, Santa Rosa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Sutter Pacific Medical Foundation, Santa Rosa
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruttererFase 1/2
- Providence Medical Foundation (site 209), Santa Rosa
Lungekreft-studier i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Arlington, VA41 studier
- Washington, DC41 studier
- Chicago, IL41 studier
- Baltimore, MD40 studier
- Nashville, TN40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Santa Rosa
- Ikke-småcellet lungekreft17 studier
- Kreft (alle typer)11 studier
- Brystkreft11 studier
- Kolorektal kreft11 studier
- Metastatisk kreft9 studier
- Prostatakreft9 studier
- Eggstokkreft7 studier
- Pankreaskreft6 studier
- Endometriekreft6 studier
- Tykktarmskreft5 studier
- Mavekreft5 studier
- Hode- og halskreft4 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.